Drug information for ALFUZOSIN HYDROCHLORIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET, EXTENDED RELEASE; ORAL 10MG Prescription AB  ALFUZOSIN HYDROCHLORIDE alfuzosin APOTEX INC 79013
2011-07-20 Letter
TABLET, EXTENDED RELEASE; ORAL 10MG Prescription AB  ALFUZOSIN HYDROCHLORIDE alfuzosin MYLAN 79014
2011-07-20 Letter
TABLET, EXTENDED RELEASE; ORAL 10MG Prescription AB  ALFUZOSIN HYDROCHLORIDE alfuzosin TORRENT PHARMS 79054
2011-07-20 Letter
TABLET, EXTENDED RELEASE; ORAL 10MG Prescription AB  ALFUZOSIN HYDROCHLORIDE alfuzosin TEVA PHARMS 79056
2011-07-20 Letter
TABLET, EXTENDED RELEASE; ORAL 10MG Prescription AB  ALFUZOSIN HYDROCHLORIDE alfuzosin SUN PHARMA GLOBAL 79057
2011-07-20 Letter
TABLET, EXTENDED RELEASE; ORAL 10MG Tentative Approval   ALFUZOSIN HYDROCHLORIDE alfuzosin AUROBINDO PHARMA 79060
TABLET, EXTENDED RELEASE; ORAL 10MG Tentative Approval   ALFUZOSIN HYDROCHLORIDE alfuzosin WOCKHARDT 90221
TABLET, EXTENDED RELEASE; ORAL 10MG Prescription AB  ALFUZOSIN HYDROCHLORIDE alfuzosin INVAGEN PHARMS 90284

Drug Adverse Effects information for ALFUZOSIN HYDROCHLORIDE

Role code Indications Reaction # Reports
PS BENIGN PROSTATIC HYPERPLASIA DIABETIC COMA 1
PS BENIGN PROSTATIC HYPERPLASIA DRUG EFFECT DECREASED 1
PS BENIGN PROSTATIC HYPERPLASIA EJACULATION DISORDER 1
PS BENIGN PROSTATIC HYPERPLASIA ERECTILE DYSFUNCTION 1
PS BENIGN PROSTATIC HYPERPLASIA HIV INFECTION 1
PS BENIGN PROSTATIC HYPERPLASIA URINARY RETENTION 1
PS BENIGN PROSTATIC HYPERPLASIA WEIGHT DECREASED 1
PS BLOOD PRESSURE INCREASED DRUG EFFECT DECREASED 1
PS BLOOD PRESSURE INCREASED URINARY RETENTION 1
PS DIABETES MELLITUS PNEUMONIA 1
PS HYPERTENSION PNEUMONIA 2
SS BENIGN PROSTATIC HYPERPLASIA DRUG INTERACTION 2
SS BENIGN PROSTATIC HYPERPLASIA LOSS OF CONSCIOUSNESS 2
SS BENIGN PROSTATIC HYPERPLASIA PRESYNCOPE 2
SS BENIGN PROSTATIC HYPERPLASIA PROSTATOMEGALY 2
SS BENIGN PROSTATIC HYPERPLASIA URINARY RETENTION 2
SS HIV TEST POSITIVE DRUG INTERACTION 4
SS HIV TEST POSITIVE LOSS OF CONSCIOUSNESS 4
SS HIV TEST POSITIVE PRESYNCOPE 4
SS HIV TEST POSITIVE PROSTATOMEGALY 4
SS HIV TEST POSITIVE URINARY RETENTION 4
SS PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 12
SS PRODUCT USED FOR UNKNOWN INDICATION LOSS OF CONSCIOUSNESS 12
SS PRODUCT USED FOR UNKNOWN INDICATION PRESYNCOPE 12
SS PRODUCT USED FOR UNKNOWN INDICATION PROSTATOMEGALY 12
SS PRODUCT USED FOR UNKNOWN INDICATION URINARY RETENTION 12
C AGGRESSION CHILLS 1
C AGGRESSION CRANIOCEREBRAL INJURY 1
C AGGRESSION DEHYDRATION 1
C AGGRESSION FALL 1
C AGGRESSION HYPERNATRAEMIA 1
C AGGRESSION HYPERTHERMIA 1
C AGGRESSION HYPOALBUMINAEMIA 1
C AGGRESSION MALNUTRITION 1
C AGGRESSION MENINGEAL DISORDER 1
C AGGRESSION MYOSITIS 1
C AGGRESSION NEGATIVISM 1
C AGGRESSION PHOTOPHOBIA 1
C AGGRESSION SOMNOLENCE 1
C ANXIETY CHILLS 1
C ANXIETY CRANIOCEREBRAL INJURY 1
C ANXIETY DEHYDRATION 1
C ANXIETY FALL 1
C ANXIETY HYPERNATRAEMIA 1
C ANXIETY HYPERTHERMIA 1
C ANXIETY HYPOALBUMINAEMIA 1
C ANXIETY MALNUTRITION 1
C ANXIETY MENINGEAL DISORDER 1
C ANXIETY MYOSITIS 1
C ANXIETY NEGATIVISM 1
C ANXIETY PHOTOPHOBIA 1
C ANXIETY SOMNOLENCE 1
C DEMENTIA ALZHEIMER'S TYPE CHILLS 1
C DEMENTIA ALZHEIMER'S TYPE CRANIOCEREBRAL INJURY 1
C DEMENTIA ALZHEIMER'S TYPE DEHYDRATION 1
C DEMENTIA ALZHEIMER'S TYPE FALL 1
C DEMENTIA ALZHEIMER'S TYPE HYPERNATRAEMIA 1
C DEMENTIA ALZHEIMER'S TYPE HYPERTHERMIA 1
C DEMENTIA ALZHEIMER'S TYPE HYPOALBUMINAEMIA 1
C DEMENTIA ALZHEIMER'S TYPE MALNUTRITION 1
C DEMENTIA ALZHEIMER'S TYPE MENINGEAL DISORDER 1
C DEMENTIA ALZHEIMER'S TYPE MYOSITIS 1
C DEMENTIA ALZHEIMER'S TYPE NEGATIVISM 1
C DEMENTIA ALZHEIMER'S TYPE PHOTOPHOBIA 1
C DEMENTIA ALZHEIMER'S TYPE SOMNOLENCE 1
C EPILEPSY CHILLS 1
C EPILEPSY CRANIOCEREBRAL INJURY 1
C EPILEPSY DEHYDRATION 1
C EPILEPSY FALL 1
C EPILEPSY HYPERNATRAEMIA 1
C EPILEPSY HYPERTHERMIA 1
C EPILEPSY HYPOALBUMINAEMIA 1
C EPILEPSY MALNUTRITION 1
C EPILEPSY MENINGEAL DISORDER 1
C EPILEPSY MYOSITIS 1
C EPILEPSY NEGATIVISM 1
C EPILEPSY PHOTOPHOBIA 1
C EPILEPSY SOMNOLENCE 1
C HYPERCHOLESTEROLAEMIA CHILLS 1
C HYPERCHOLESTEROLAEMIA CRANIOCEREBRAL INJURY 1
C HYPERCHOLESTEROLAEMIA DEHYDRATION 1
C HYPERCHOLESTEROLAEMIA FALL 1
C HYPERCHOLESTEROLAEMIA HYPERNATRAEMIA 1
C HYPERCHOLESTEROLAEMIA HYPERTHERMIA 1
C HYPERCHOLESTEROLAEMIA HYPOALBUMINAEMIA 1
C HYPERCHOLESTEROLAEMIA MALNUTRITION 1
C HYPERCHOLESTEROLAEMIA MENINGEAL DISORDER 1
C HYPERCHOLESTEROLAEMIA MYOSITIS 1
C HYPERCHOLESTEROLAEMIA NEGATIVISM 1
C HYPERCHOLESTEROLAEMIA PHOTOPHOBIA 1
C HYPERCHOLESTEROLAEMIA SOMNOLENCE 1
C HYPERTENSION CHILLS 1
C HYPERTENSION CRANIOCEREBRAL INJURY 1
C HYPERTENSION DEHYDRATION 1
C HYPERTENSION FALL 1
C HYPERTENSION HYPERNATRAEMIA 1
C HYPERTENSION HYPERTHERMIA 1
C HYPERTENSION HYPOALBUMINAEMIA 1
C HYPERTENSION MALNUTRITION 1
C HYPERTENSION MENINGEAL DISORDER 1
C HYPERTENSION MYOSITIS 1
C HYPERTENSION NEGATIVISM 1
C HYPERTENSION PHOTOPHOBIA 1
C HYPERTENSION SOMNOLENCE 1
C STEM CELL TRANSPLANT ACUTE PULMONARY OEDEMA 1
C STEM CELL TRANSPLANT ACUTE RESPIRATORY DISTRESS SYNDROME 1
C STEM CELL TRANSPLANT BRAIN NATRIURETIC PEPTIDE INCREASED 1
C STEM CELL TRANSPLANT CHOLESTASIS 1
C STEM CELL TRANSPLANT CYTOLYTIC HEPATITIS 1
C STEM CELL TRANSPLANT ENTEROCOCCUS TEST POSITIVE 1
C STEM CELL TRANSPLANT PROTHROMBIN TIME PROLONGED 1
C STEM CELL TRANSPLANT PROTHROMBIN TIME SHORTENED 1
C STEM CELL TRANSPLANT SEPSIS 1
Ads by Google